Trial Details

COMPLETED
Basic Information
Clinical ID c981
Identifier NCT04607837
Trial Title Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: Etrasimod|DRUG: Placebo
Participant Information
Sponsor Pfizer
City Dothan
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2021-04-12
Primary Completion Date 2024-06-19
Completion Date 2024-06-19